Creator marketing enforcement actions, lawsuits, and self regulatory decisions.
Dark Reachnoun The exposure your brand gets from creator videos nobody at your brand has seen, reviewed, or approved.
Dark Reach is exposure. This page shows what exposure of this kind can turn into: public enforcement actions and lawsuits in the United States over creator, influencer, affiliate, and social media content. Each entry is a few factual sentences with a link to its source. Watchword adds to it every week.
No entry here is a case Watchword worked on, and none is presented as a brand’s Dark Reach. They are the public record of what happens when a disclosure, a claim, or a brand safety issue on a platform gets noticed. Most involve content a creator or affiliate made on a brand’s behalf. Some involve a company’s own social posts; those are labeled, and they are here because they show how regulators treat a claim once it is on a platform, whoever posted it.
65 entries from 2023 to 2026: 3 by the FTC, 17 by the FDA, 18 by private plaintiffs, 27 by self regulatory bodies. 44 involve content a creator, affiliate, or brand partner made on a brand's behalf; 21 involve a company's own social posts or storefront. Coverage begins January 2023. Last reviewed November 9, 2026. Last new entry November 9, 2026. A filed lawsuit or complaint is an allegation, not a finding. Nothing on this page is legal advice.
FDA issued a warning letter stating that the company's website and its account on X contained false or misleading representations about compounded semaglutide and tirzepatide products, which FDA stated caused the products to be misbranded. The letter cites posts by @Ronan_Rx, including a bio header stating 'Explore GLP-1s like Ozempic' and a video the account reposted and pinned at the top of its feed that described the products as 'American made' and 'farm-to-table drugs,' which FDA stated created a misleading impression about the products' origin because, based on FDA's records, the active pharmaceutical ingredient was not made in the U.S.
FDA issued a warning letter citing violations of current good manufacturing practice regulations that it stated were observed during an April 2026 inspection of the company's ophthalmic drug manufacturing facility in Vietnam, including environmental monitoring and cleaning records that FDA stated were falsified. The letter also states that seven ROHTO Cooling Eye Drops products were unapproved new drugs and misbranded, based on a review of the product labeling, the company's website, and its Instagram account, and quotes an @rohtoeyedrops Instagram post saying the Dual Light Relief product 'employs HydroCorneal™ protection technology to protect corneal cells from UV damage.'
FDA issued a warning letter stating that HClear for him and FemiClear Genital Herpes Symptoms were unapproved new drugs. The letter cites the company's website and its Facebook and Instagram accounts, which it says direct consumers to the website to buy the products, including Facebook posts dated September 10, 2024 and January 29, 2026 and an Instagram post dated April 4, 2025.
Warning letter: Bioactive Services USA, LLC / Herstat Inc.
FDA issued a warning letter stating that Herstat GST, labeled as a 'Genital Sore Treatment,' was an unapproved new drug. The letter cites the company's websites and its Facebook and Instagram accounts, which it says direct consumers to the website to buy its products, including an October 12, 2022 post on both accounts describing the product as providing relief from the symptoms of genital sores.
A parent and a minor filed a proposed class action (Vettel v. Sephora USA, Inc., No. 3:26-cv-09653, N.D. Cal.) alleging that Sephora sells more than 1,600 products containing ingredients the complaint calls unsuitable for children, described as a majority of the skincare products offered on Sephora.com, without age related warnings at the point of sale. The complaint also describes Sephora's paid influencer program and the Sephora x TikTok Incubator Program, established with TikTok and the agency Digitas, and alleges that brands sold through Sephora sent complimentary skincare and curated packages to young social media creators. These are allegations; no finding has been made.
Class action filed: Blockratize, Inc. dba Polymarket
A consumer filed a proposed class action (Moeller v. Blockratize, Inc., No. 1:26-cv-03083, D.D.C.) alleging that Polymarket paid content creators to film betting videos on copies of its website that ran on the company's own servers, so that the bets and wins shown were not real, and that it instructed the creators not to disclose that they were paid. These are allegations; no finding has been made.
According to a September 29, 2026 summary by the law firm Kelley Drye, CARU, as part of its routine monitoring, 'found posts from kid influencers that promoted Coco Vida clothing on Instagram,' and although the company had hired the influencers to post content, CARU was concerned that the influencers did not clearly disclose their connection to the company. Kelley Drye reports that CARU recommended Coco Vida ensure that influencers clearly disclose their connection to the company 'in a way that is understandable to children' and that the content is readily identifiable as advertising, and that it implement procedures to monitor influencers. The summary does not state whether Coco Vida agreed to comply or appealed, and no public decision summary for this case could be found on the BBB National Programs website. CARU is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Warning letter: R3 Medical Companies (Bello Bio, LLC and Regen Suppliers, LLC)
FDA issued a warning letter stating that umbilical cord and exosome products sold under the ReBella name were unapproved new drugs and unlicensed biological products, citing the company's websites and its YouTube, TikTok, Instagram, and Facebook accounts, including a March 5, 2026 YouTube video in which an employee showed vials of the products to a patient and described the exosomes as 'very anti-inflammatory.'
The National Association of Consumer Advocates sued Polymarket, its CEO, and its chief marketing officer in D.C. Superior Court (No. 2026-CAB-004388) under the District's Consumer Protection Procedures Act, alleging that influencers were paid to promote the platform without disclosure, that creators filmed bets on a simulated version of the platform, and that the company paid clippers to make and post short clips of its ads with instructions not to make them feel like ads. These are allegations; no finding has been made.
FDA issued a warning letter stating that a Prostatitis Remission Cream was an unapproved new drug and misbranded. The letter cites the company's website and its TikTok Shop storefront as places the product was offered and copies TikTok's Global Head of Trust and Safety.
A consumer filed a proposed class action (Lupea v. Gymshark USA, Inc., No. 1:26-cv-05073, S.D.N.Y.) alleging that Gymshark had influencers on Instagram, YouTube, and TikTok promote its apparel without disclosing that they were paid, and that exclusivity arrangements with those influencers were not disclosed to consumers. These are allegations; no finding has been made.
NAD's inquiry into Kalshi's advertising included whether 'material connections between Kalshi and influencers or affiliates were clearly and conspicuously disclosed in social media advertising' and 'whether Kalshi takes adequate steps to ensure compliance with the Federal Trade Commission's Guides Concerning the Use of Endorsements and Testimonials in Advertising.' The decision summary states that 'Kalshi declined to participate in the NAD self-regulatory process,' so NAD made no recommendations, and that NAD 'will refer this matter to the appropriate regulatory authorities, including relevant state Attorneys General, and to the platforms on which the advertising appeared...' The summary names no platform. No government action has been taken: the referral is NAD's own and is prospective. NAD is an industry self regulatory body, not a government agency, and a referral is not a legal finding.
The FTC sued multilevel marketer Amare Global in federal court in the Central District of California, alleging that the company and its brand partners advertised Kids Happy Juice and related supplements on Instagram, TikTok, YouTube, and Facebook with unsubstantiated claims to treat depression, anxiety, and ADHD, and that the company made deceptive earnings claims to people it recruited to join. These are allegations; no finding has been made.
Shenzhen Zhihuida Technology Co., Ltd. and Gaosto Ltd. voluntarily dismissed with prejudice their lawsuit against PetPivot Inc., two TikTok accounts, two individuals, and an unnamed defendant (No. 4:26-cv-00054, E.D. Tex.), after the parties jointly asked the court to stay the case pending settlement. The docket records the notice of voluntary dismissal on May 15, 2026, and the court's acknowledgement on May 19, 2026, which recounts that 'Plaintiffs file this notice voluntarily dismissing, with prejudice, all their claims filed against Defendants herein.' No finding was made. The docket does not state that the case settled or report any terms.
FDA issued a warning letter stating that the SaniiSwab nasal product was an unapproved new drug and misbranded, citing Facebook and Instagram posts about preventing illness and stopping the spread of germs during flu season, and a website statement that the product was 'FDA OTC approved,' which FDA said was false or misleading because the product is not the subject of an approved application.
FDA issued a warning letter stating that the Super Antioxidant (OPCXtra) product was an unapproved new drug and misbranded, citing disease claims on the company's website and noting that the company's Facebook page directed consumers to that website.
NAD 'reviewed influencer marketing practices and recommended that Niagen ensure material connections are clearly and conspicuously disclosed in both audio and visual portions of content, consistent with the FTC Endorsement Guides and NAD's guidance.' Niagen said it 'will appeal NAD's decision.' The summary names no platform. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Shenzhen Zhihuida Technology Co., Ltd., which the complaint identifies as owner of the registered Meowant trademark for pet litter boxes, and Gaosto Ltd., which it identifies as the operator of the Meowant TikTok store under licence, sued PetPivot Inc., two accounts the complaint identifies as TikTok accounts, two individuals, and an unnamed defendant in the Eastern District of Texas (No. 4:26-cv-00054). The complaint alleges that PetPivot 'engaged' the other defendants, that they 'receive direction and instructions from Defendant PetPivot,' that they created 'fake review videos that widely spread false, misleading, and deceptive statements' about the Meowant products, that they 'falsely claimed that Plaintiffs' products were sold at $300, a price point at which Plaintiffs never listed' them, and that the videos 'all contain direct links to Defendant PetPivot's TikTok Shop storefront.' These are allegations; no finding has been made.
In Roadget Business Pte. Ltd. v. PDD Holdings Inc. (No. 1:24-cv-02402, D.D.C.), a suit by the company known as Shein, the court dismissed PDD Holdings for lack of personal jurisdiction and denied WhaleCo's motion to dismiss the false advertising count. Shein alleges that WhaleCo hired influencers, that its influencer guidelines instructed them to include an Instagram caption saying Temu was cheaper and better quality than Shein, and that influencers published statements Shein alleges are false. Ruling only on whether the claim could proceed, and drawing inferences in Shein's favor, the court found that a reasonable consumer could believe the influencers actually compared the two companies' clothes, and that the influencer statements, as alleged, were commercial advertisement that could be imputed to WhaleCo. The court did not decide whether the statements were false.
FDA issued a warning letter stating that iKids-Growth products promoted as dietary supplements were unapproved new drugs and misbranded, citing September 2024 posts on the company's Facebook page claiming the products enhance IGF-1 levels and promote height increase. FDA also stated that its laboratory analysis found the undeclared ingredient ibutamoren mesylate in samples of both products.
Self regulatory decision: One Home Brands, Inc. d/b/a Blueland
In a challenge brought by The Procter & Gamble Company, NAD considered TikTok Shop posts by creators promoting Blueland products. For creators who were provided free product and whose only other relationship to Blueland was participation in the TikTok shop affiliate program, NAD found that TikTok's automated disclosure 'creator earns commission' sufficiently informs consumers that a commercial relationship exists and that 'no additional disclosure is necessary.' Blueland identified posts from four creators who may have received additional compensation and asked them to add partnership disclosures or discontinue the posts, which NAD said it would treat for compliance purposes as though it had recommended them. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
NAD stated that 'the challenged TikTok posts require a clear and conspicuous material connection disclosure and found no support for the argument that because an influencer linked to a TikTok shop, consumers would know the influencer had a material connection to the seller.' NAD also found that including a TikTok store link 'does not itself disclose a material connection,' and said TikTok's built in disclosure tool, 'Creator earns commission,' which appears at the bottom left portion of videos and is relatively small, 'could be easily missed by consumers.' Reus Research said it 'will comply with NAD's recommendations.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Self regulatoryBrand's own postsFood and beverageLink
Self regulatory decision: MrBeastYouTube, LLC and Feastables
CARU stated that 'video descriptions and pinned comments contained advertising content unrelated to the videos' and that 'this content was not clearly labeled or otherwise identifiable as advertising to children in the audience.' CARU recommended that the channel update its advertising practices to ensure that all advertisements are identifiable as ads to children. The parties said they 'do not agree with all the conclusions made in the decision or the premises on which they were based,' said various issues relate to practices long since revised or discontinued, and said they 'will take CARU's concerns under advisement' in developing future advertisements. CARU is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
In Negreanu v. Revolve Group, Inc. (No. 2:25-cv-03186, C.D. Cal.), a proposed class action alleging undisclosed paid influencer posts on Instagram, the court granted the Revolve entity defendants' motion to compel arbitration and strike the class claims, and ordered status reports on the arbitration. The order did not decide the allegations; no finding has been made.
FDA issued a warning letter stating that homeopathic oral care gels and rinses were unapproved new drugs, citing claims on the company's Facebook, Instagram, and YouTube accounts, including a Facebook post about recovering faster from dental surgery.
The parties in the Alo Yoga influencer-disclosure class action (Sulici v. Color Image Apparel d/b/a Alo Yoga, No. 1:25-cv-03928, N.D. Ill.) told the court on September 11, 2025 that they had resolved the case, and on October 2, 2025 reported that they had fully executed a settlement agreement. On November 19, 2025, after the plaintiffs filed a notice of voluntary dismissal, the court dismissed the case with prejudice as to the named plaintiffs' claims and without prejudice as to the claims of putative class members. The docket does not state the settlement terms.
Private plaintiffCreator contentFood and beverageLink
Court ruling: Celsius Holdings Inc.
Celsius Holdings reported that in the putative class action filed January 22, 2025 in the Central District of California, in which the plaintiff alleges that consumers 'were misled regarding the alleged financial relationship between Celsius and the individual defendants' who 'allegedly promoted the Company's products on social media,' the court dismissed the complaint with leave to amend on August 18, 2025. The plaintiff filed an amended complaint on September 15, 2025, the defendants moved to dismiss it on October 15, 2025, the court heard argument on February 3, 2026, and the motion remains pending. A dismissal with leave to amend decides only whether the claims as pleaded may proceed. These are allegations; no finding has been made.
Self regulatoryBrand's own postsOther consumerLink
Self regulatory decision: Agendia, Inc.
In a challenge brought by Genomic Health, Inc., NAD considered posts that 'appeared on Agendia's LinkedIn account and linked to articles in which a prominent surgical oncologist is interviewed.' NAD 'recommended that Agendia clearly and conspicuously disclose its connection to the doctor in its posts to accurately communicate the nature of their relationship.' The decision summary does not state whether Agendia agreed to comply or appealed. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
FDA issued a warning letter stating that Supergoop! PLAY SPF 50 Body Mousse, an over-the-counter sunscreen, was misbranded, that no FDA-approved application was in effect for it, and that no final order authorizes marketing a sunscreen in a mousse (foam) dosage form. The letter cites the company website and its Instagram and Facebook pages, which the letter says direct consumers to the website, including an Instagram post describing the product as a sunscreen mousse.
The U.S. Court of Appeals for the Eleventh Circuit (Pop v. LuliFama.com LLC, No. 24-11048) affirmed dismissal of a proposed class action against Luli Fama swimwear and several Instagram influencers alleging undisclosed paid endorsements, holding that the complaint did not plead the alleged fraud with the particularity Rule 9(b) requires.
FDA issued a warning letter stating that 7-hydroxymitragynine (7-OH) tablets, sublingual strips, and shots were unapproved new drugs and that a 7-OH drink mix was adulterated, citing the company's Instagram posts from May 2025, including one promoting 'calm, clarity, & relief.'
FDA's Office of Prescription Drug Promotion issued a warning letter stating that an Instagram post by Sprout's CEO on the account 'cindypinkceo' was false or misleading because it presented benefits of the prescription drug Addyi without any risk information and did not disclose the drug's full indication and limitations of use.
Self regulatory decision: HB USA Holdings, Inc. (Huda Beauty)
NAD stated that 'when an advertiser and an influencer have a longstanding, informal relationship that includes providing free products, and the advertiser is aware of potentially unsupported claims made by the influencer, the advertiser may be required to take additional corrective action.' NAD recommended that Huda Beauty 'make a good-faith attempt to request that the influencer remove the TikTok video.' Huda Beauty said it 'will comply with NAD's decision and recommendation.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
A Florida consumer filed a proposed class action (Pop v. Beach Bunny Swimwear, Inc., No. 2:25-cv-04085, C.D. Cal.) against Beach Bunny Swimwear and six influencers, alleging that the influencers promoted the brand's swimwear on Instagram without disclosing that they were compensated, and that the plaintiff and class members paid a premium as a result. These are allegations; no finding has been made.
NAD considered Instagram posts by a lifestyle influencer who had a paid relationship with Skims, and stated that 'the Skims brand was tagged in the shared image, which qualifies the post as an endorsement requiring clear and conspicuous material connection disclosure.' The posts were modified, and NAD said those modifications 'will be treated, for compliance purposes, as though NAD recommended the modifications and 1Up Sports Marketing and Ms. Mahomes agreed to comply.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
A Florida consumer filed a proposed class action (Negreanu v. Revolve Group, Inc., No. 2:25-cv-03186, C.D. Cal.) against Revolve, related companies, and three influencers, alleging that Revolve had influencers promote its clothing on Instagram without disclosing that they were paid, and that 'relying on the undisclosed endorsements and misleading advertising, Plaintiff and the Class Members (defined below) purchased products from REVOLVE and paid a premium.' The complaint names no other platform for the posts at issue. These are allegations; no finding has been made.
Class action filed: Color Image Apparel dba Alo Yoga
Two consumers filed a proposed class action (Sulici v. Color Image Apparel, Inc. d/b/a Alo Yoga, No. 1:25-cv-03928, N.D. Ill.) against Alo Yoga, a related company, and fifteen individuals the complaint calls 'the Influencers,' alleging that they promoted Alo products on Instagram 'without disclosing the fact that they were compensated to do it,' and that 'Plaintiffs and the Class Members purchased ALO products and paid a premium.' The complaint names no other platform for the posts at issue. These are allegations; no finding has been made.
FDA issued a warning letter stating that CBD products for animals were unapproved new animal drugs and that certain of them were adulterated animal foods, citing claims on the company website, a May 2024 Instagram post, and Pinterest pins.
FDA issued a warning letter stating that CBD products for animals and humans were unapproved drugs, citing claims on the company website and August 2024 Facebook and Instagram posts about easing hip dysplasia discomfort in dogs.
NAD considered Instagram posts by two celebrity endorsers promoting Skims. For one endorser's posts, NAD determined that 'a clear and conspicuous material connection disclosure was necessary' and 'recommended that Skims take reasonable steps to have Mahomes discontinue or modify the challenged posts to include an appropriate disclosure.' Skims argued those posts did not explicitly reference Skims and were stylized, and NAD determined that the images, while polished, did not inherently signal sponsorship. For the other endorser, Skims asked her to modify three posts to add #ad or #sponsored, and NAD said that 'for compliance purposes, NAD will treat this voluntary modification as though it was recommended by NAD and agreed upon by Skims.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
FDA issued a warning letter stating that TKTX topical numbing creams were unapproved new drugs, citing the company's Facebook and Instagram accounts that directed consumers to its website to buy the products.
NAD stated that 'a significant minority of the audience might not be aware of Hart's affiliations due to varying levels of engagement with athletic brands or celebrity endorsements,' and recommended 'a clear and conspicuous disclosure of Hart's relationship with JPMC and Fabletics.' Hart's team advised NAD that the posts had been updated to include disclosures of these material connections and said Hart and the team are committed to complying with the Federal Trade Commission's Endorsement Guides. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Self regulatory decision: JPMorgan Chase Bank, N.A.
NAD determined that a celebrity endorser's disclosure of his relationship with Chase 'was not clear and conspicuous' because the hashtag #chasepartner was positioned below the fold, requiring users to click 'more' to view it. The disclosure was changed to #chase_partner and moved above the fold, and NAD said those modifications will be treated 'for compliance purposes, as though NAD recommended the modifications and JPMC agreed to comply.' JPMorgan Chase said it would follow NAD's recommendations. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
NAD recommended 'a clear and conspicuous disclosure of Hart's relationship with Fabletics,' noting that many audience members might not know of the celebrity endorser's affiliation. NAD found that the original posts commonly only tagged or referenced the Fabletics accounts and that the disclosure appeared after the 'more' button, and that revised posts include disclosures such as #FableticsPartner placed above the 'more' button. Fabletics said it 'agrees to comply with NAD's recommendations' and represented that it will require Hart to include appropriate disclosures in all future posts. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Class action filed: Roadget Business Pte. Ltd. dba Shein
Eight consumers filed a proposed class action (Bengoechea v. Roadget Business Pte. Ltd. d/b/a Shein, No. 1:25-cv-01402, N.D. Ill.) against three Shein entities and seven individuals the complaint calls 'Influencers,' alleging that 'despite being compensated for endorsing the brand by pretending to wear SHEIN products, none of the Influencers use the paid partnership tag suggested by the FTC and Instagram,' and that 'some of the Influencers provide a buried small disclosure so it would be almost impossible for a social media user to discern the fact that the post was sponsored.' These are allegations; no finding has been made.
NAD stated that the disclosure #giftedbyrevolve 'runs words together and makes it difficult for consumers to understand,' and that 'tagging brands, particularly when multiple brands are tagged, does not make clear that a brand is sponsoring the post, or which brand is sponsoring the post.' NAD recommended that Revolve 'take steps to ensure that its influencers' posts make clear the influencers' material connection to the brand.' Revolve said it 'will comply with NAD's decision and recommendations' and committed to modified Brand Ambassador Guidelines and Checkout Terms. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Private plaintiffCreator contentFood and beverageLink
Class action filed: Celsius Holdings Inc.
A California consumer filed a proposed class action (Dubreu v. Celsius Holdings Inc., No. 5:25-cv-00180, C.D. Cal.) against Celsius and three individuals the complaint calls 'influencers,' alleging that 'despite being handsomely compensated for pretending to drink and promoting Celsius brands, none of the Influencers use the paid partnership label suggested by the FTC or buried a small disclosure so it would be almost impossible for a social media user to discern the fact that the post was sponsored.' The complaint identifies each individual by an Instagram account and names no other platform for the posts at issue. These are allegations; no finding has been made.
NAD recommended that NuOrganic 'ensure any affiliates with which it has a financial relationship include clear and conspicuous disclosures of the material connection to NuOrganic in posts about the product,' and recommended that the company 'discontinue the videos containing the unsupported claims.' NuOrganic said it 'will comply with NAD's recommendations.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
In a challenge brought by Mielle Organics, LLC, NAD 'determined that Kreyol Essence, LLC failed to properly disclose a material connection to an influencer.' The issue NAD considered was whether a hair influencer promoting Kreyol Essence products on social media platforms, including TikTok, Facebook, and YouTube, failed to disclose her financial relationship and material connection with the brand clearly and conspicuously. Kreyol Essence voluntarily asked the influencer to remove certain posts, voluntarily discontinued all challenged advertising, and said it will comply with NAD's recommendations. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Sol de Janeiro sued MCoBeauty and related companies in the Southern District of New York (No. 1:24-cv-08862), pleading false advertising and trademark infringement under 15 U.S.C. 1125 and a violation of New York General Business Law section 349, with the infringement count directed at 'colorable imitations of Sol de Janeiro's Trade Dress.' The complaint alleges that a video advertisement on MCoBeauty's YouTube channel 'features the influencer stating that MCoBeauty Fragrance Mist No. 1 smells exactly like Sol de Janeiro Cheirosa Perfume Mist 40,' and that an influencer's Instagram post made 'false and misleading claims, including that the Infringing Products are copies of, or similar to, the Sol de Janeiro Products,' a post the complaint says MCoBeauty 'affirmatively sponsored' by liking it and commenting 'Love it!' These are allegations; no finding has been made.
NAD stated that the hashtag #drunkelephantpartner in an influencer's TikTok post was 'not clear and conspicuous' because it appeared on the fifth line and required clicking a hyperlink to view, and recommended that the hashtag appear clearly and conspicuously without having to click a hyperlink and as separate words. For an unpaid influencer who received free product, NAD found that 'receiving free product constitutes a material connection that requires disclosure' and recommended the post be modified. Drunk Elephant said it 'will comply with NAD's recommendations.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Competitor lawsuit filed: PDD Holdings Inc. and WhaleCo Inc. (Temu)
Roadget Business Pte. Ltd., the plaintiff known as Shein, sued PDD Holdings Inc., WhaleCo Inc., which runs Temu, and unnamed defendants in the U.S. District Court for the District of Columbia on August 19, 2024 (No. 1:24-cv-02402). The court's January 2026 opinion describes Shein's allegations that WhaleCo's influencer guidelines instructed influencers to include an Instagram caption saying Temu was cheaper and better quality than Shein, and that several influencers published such statements while acknowledging a paid partnership with Temu. These are allegations. In that opinion the court dismissed PDD Holdings for lack of personal jurisdiction and denied WhaleCo's motion to dismiss the false advertising count.
FDA issued a warning letter stating that the company's chemical peel products were unapproved new drugs, citing claims on its website and on Instagram posts, including an August 2023 post stating that chemical peels help skin disorders like acne and rosacea.
Self regulatory decision: Content Media Group FZC, LLC
CARU reviewed the Vlad and Niki YouTube channels and found that the company qualifies as an endorser where it is required to produce videos under licensing agreements while sharing revenue from product sales, so that a clear and conspicuous disclosure of the material connection must appear in the videos. CARU recommended disclosure 'in both text and audio in the video itself that is clear for children to understand' at standardized points, cautioned that advertisers should not rely on platform disclosure tools, which it said 'are often not sufficient to comply with CARU's Advertising Guidelines regarding clear and conspicuous disclosures to children,' and said the disclosure 'this video features products that Vlad and Niki helped create' is insufficient, suggesting wording such as 'This is an ad for our Vlad and Niki toy.' The company said it 'will work diligently to comply with the recommendations set forth in the final decision.' CARU is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
NAD recommended that Fenty Skin require an influencer to 'modify a challenged Instagram post to include a clear and conspicuous material connection disclosure in the video demonstration itself,' and said Fenty Skin's re-post of that video to its own Instagram page 'should likewise have a modified disclosure.' For a second influencer, NAD said Fenty Skin removed the post from its own Instagram and will re-post only if the disclosure is corrected. Fenty Skin said it 'will comply with NAD's Decision' and 'supports the self-regulatory process.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
NAD reviewed product rankings and endorsements on the Bare Beauty Babes blog and on Instagram. NAD stated that 'there was no evidence in the record related to the qualifications or expertise of the endorser,' and that 'the record was silent as to the criteria used to rate or rank the products in the category and whether the endorser reviewed and ranked all products.' NAD recommended that 'endorsers disclose their connection to the Naked & Thriving brand when that connection is not reasonably communicated by the context of the post.' The advertiser voluntarily modified the website during the inquiry, adding a disclosure of its connection and removing product recommendations, and said it 'agrees to comply with NAD's recommendations' although it 'disagrees with certain aspects of NAD's decision.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Self regulatory decision: Ginger Health Company (Wonderbelly)
In a challenge brought by Haleon, plc, Ginger Health Company 'voluntarily modified certain claims for its Wonderbelly Antacids,' including modifying its influencer practices to add '#ad #WonderbellyPartner to the beginning of each influencer post' and 'requiring its influencers to include a verbal notice of their partnership with Wonderbelly in any video influencer material.' NAD recommended that Wonderbelly discontinue the 'not an ad' language used in a celebrity endorser's post, and 'also recommended that when reposting influencer content, Wonderbelly clearly and conspicuously disclose that the influencers have a material connection to Wonderbelly.' Ginger Health said it 'will abide by the recommendations made by NAD.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Self regulatory decision: Cariuma Central Pte., Ltd.
NAD reviewed Instagram and Facebook posts promoting Cariuma shoes that appeared on the accounts of Travel + Leisure, US Weekly, and The Quality Edit. NAD concluded that even though the posts were labeled 'Sponsored,' it is not clear whether the posts were sponsored by the publisher or by Cariuma, and recommended that Cariuma 'clearly and conspicuously disclose its material connection to the endorser and publisher.' Cariuma said it 'will comply with the NAD's recommendation' while noting it 'respectfully disagrees with the NAD's decision but is committed to accurate and truthful advertising.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
Warning letter: American Beverage Association, The Canadian Sugar Institute, and 12 registered dietitians and other online health influencers
FTC staff sent warning letters to two trade associations and 12 registered dietitians and other online health influencers over Instagram and TikTok posts promoting the safety of aspartame or the consumption of sugar-containing products. FTC stated the letters identified what appeared to be paid posts that either did not disclose a material connection or had disclosures that may be inadequate, and noted that recipients could face civil penalties of up to $50,120 per violation for future failures to disclose unexpected material connections.
Self regulatory decision: Goose Creek Candles, LLC
NAD reviewed videos promoting Goose Creek candles and found that 'Goose Creek's relationship with @TheCandleChannel vlogger is a connection that would likely affect the weight or credibility of the endorsements and is a material connection that must be clearly and conspicuously disclosed.' NAD recommended that Goose Creek require that channel to modify any video created after the date of employment to include a clear and conspicuous material connection disclosure, and that videos featuring employed actors disclose, in both audio and video, that actors have been employed. Goose Creek said it 'agrees to comply with the NAD's recommendations regarding its advertising.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
NAD reviewed how Renue by Science markets dietary supplements 'on its website, affiliated editorial websites, and via YouTube videos published by affiliated endorsers.' For affiliated websites selling the company's products, NAD recommended that the sites 'clearly and conspicuously disclose that the affiliates receive payments based on sales of Renue by Science's products.' NAD also recommended that the company modify or discontinue certain challenged YouTube videos to disclose the advertiser's relationship to the speaker, and that it inform an employee of her obligation to clearly and conspicuously disclose in the video that she is an employee. Renue by Science said it 'has voluntarily complied with the NAD's recommendations.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
CARU found that Roblox did not comply with its advertising guidelines, stating that 'social media influencers in Roblox's Influencer Program who had large child audiences did not clearly and conspicuously disclose their material connection to Roblox in their videos in a way children can understand.' CARU also stated that influencers in the Video Stars Program who promoted their unique Star Code did not clearly and conspicuously disclose, in a way children can understand, that they would receive a commission. Roblox disagreed with some of the recommendations and statements in the decision, and said it would ask that its influencers with child-directed content use the word 'paid' in their disclosures. CARU is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
NAD reviewed Vegamour's own Facebook and Instagram posts promoting Gro Ageless Anti-Gray Hair Serum, including a post reading 'FINALLY a serum that can delay grey hair. Does it Work? We tried it and here's our review,' which linked to two review sites. NAD said that if a review site is not independent, then the opinions shared are advertising. Vegamour voluntarily discontinued the posts and made the review sites private until appropriate disclosures could be added, so NAD did not review the claims on their merits. NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
NAD reviewed Routine Wellness's dissemination of third-party claims about its shampoo and conditioner on Facebook and Instagram. NAD said that 'when an advertiser quotes, restates, links to, or otherwise disseminates claims made about its product by a third party, those same third-party claims become advertising claims made by the advertiser for which the advertiser must have substantiation.' Routine Wellness voluntarily discontinued the posts during the inquiry and said it was 'pleased with NAD's decision and will comply with its recommendations.' NAD is an industry self regulatory body, not a government agency, and its recommendations are not legal findings.
The FTC announced that three high-level doTERRA distributors agreed to court orders requiring each to pay a $15,000 civil penalty. In complaints filed by the Department of Justice on the FTC's behalf under the FTC Act and the COVID-19 Consumer Protection Act, the government alleged that the distributors claimed in a series of webinars in early 2022 that doTERRA essential oils and dietary supplements could treat, prevent, or cure COVID-19.
What counts. An entry is included when a US federal agency, a state attorney general, a private plaintiff, or a US advertising self regulatory body (NAD, CARU, or ERSP, all of BBB National Programs) took a public action, and the public record cites creator, influencer, affiliate, or social media content as part of it: a post, a video, a storefront, a paid endorsement, or a missing disclosure. Actions about fake reviews alone, with no creator or social component, are not included.
Two kinds of entry. "Creator content" means a creator, affiliate, influencer, or brand partner made the post or video on a brand's behalf. That is Dark Reach. "Brand's own posts" means the company's own account or storefront was cited. Those entries are included because they show how a regulator or a self regulatory body treats a product claim once it is on a platform, whoever posted it. Use the "Whose content" filter to view either set alone.
How entries are written. One sentence per entry describing what happened, in plain language, with the date, the actor, the company, and the platforms cited. Every entry links to the primary source or to a law firm or legal publication that names the case. Watchword reads the source before publishing. A filed lawsuit or complaint is an allegation and is labeled as one. Where the source reports a later ruling, settlement, or dismissal, that is recorded as its own entry.
What this is not. This is a record of what is public, not a complete list. Some actions are never announced, and some filings are only visible on paid court dockets. Nothing here is legal advice, and no entry is a determination by Watchword that any company or creator did anything wrong.
Updates. Watchword reviews new FTC and FDA actions, state attorney general announcements, court filings, and NAD and CARU decisions each week and adds entries that meet the standard above. Corrections: hello@usewatchword.com.
Use the data. The full record is available as risk.json. Quote or cite it with attribution.
Suggested citation: Watchword Labs, LLC. "The risk of Dark Reach: a running record of enforcement, lawsuits, and self regulatory decisions over creator content." usewatchword.com/risk. Updated November 9, 2026.